Secerov-Ermenc, A.; Peterlin, P.; Velenik, V.; Jeromen-Peressutti, A.; But-Hadzic, J.; Anderluh, F.; Segedin, B.
PET/CT and MR Improve Interobserver Agreement in Primary Tumor Determination for Radiotherapy in Esophageal Squamous Cell Cancer. Diagnostics 2025, 15, 690.
https://doi.org/10.3390/diagnostics15060690
AMA Style
Secerov-Ermenc A, Peterlin P, Velenik V, Jeromen-Peressutti A, But-Hadzic J, Anderluh F, Segedin B.
PET/CT and MR Improve Interobserver Agreement in Primary Tumor Determination for Radiotherapy in Esophageal Squamous Cell Cancer. Diagnostics. 2025; 15(6):690.
https://doi.org/10.3390/diagnostics15060690
Chicago/Turabian Style
Secerov-Ermenc, Ajra, Primoz Peterlin, Vaneja Velenik, Ana Jeromen-Peressutti, Jasna But-Hadzic, Franc Anderluh, and Barbara Segedin.
2025. "PET/CT and MR Improve Interobserver Agreement in Primary Tumor Determination for Radiotherapy in Esophageal Squamous Cell Cancer" Diagnostics 15, no. 6: 690.
https://doi.org/10.3390/diagnostics15060690
APA Style
Secerov-Ermenc, A., Peterlin, P., Velenik, V., Jeromen-Peressutti, A., But-Hadzic, J., Anderluh, F., & Segedin, B.
(2025). PET/CT and MR Improve Interobserver Agreement in Primary Tumor Determination for Radiotherapy in Esophageal Squamous Cell Cancer. Diagnostics, 15(6), 690.
https://doi.org/10.3390/diagnostics15060690
